मैट्रिक्स
 
 
गोदावरी ड्रग्स > कंपनी इतिहास > Pharmaceuticals > कंपनी इतिहास का गोदावरी ड्रग्स - बीएसई: 530317, NSE: N.A

गोदावरी ड्रग्स

बीएसई: 530317  |  NSE: N.A  |  ISIN: INE362C01012  |  Pharmaceuticals

कंपनी इतिहास - गोदावरी ड्रग्स
GODAVARI DRUGS LIMITED was incorporated as a private limited  company
 on December 2nd 1987 and subsequently converted into a public limited
 company on September 25th 1992.  It was promoted by Mr. Ghanshyam
 Jaju, Mr. Mukund Kakani and Mr. P.C. Shrimal.  The company has set up
 a project to manufacture 180 TPA at SULPHAMETHOXAZOLE (SMX) in 1988. 
 The 
 project is located at Maharashtra Industrial Development Corporation
 (MIDC), Nanded, a notified class 'C' backward district in
 Maharashtra.  The project was fully commissioned on July 3rd 1989.
 
 MAIN OBJECTS OF THE COMPANY:
 
 The main objects at the Company as detailed in the Memorandum at
 Association of the Company are:
 
 1. To manufacture, refine, purchase, sell, prepare, import, export
 all classes and kinds of drugs including pharmaceutical preparations
 and formulations, fine organics and inorganic chemicals, raw
 materials and intermediates for drugs.
 
 2. To manufacture and/or deal in all types at drugs, chemicals,
 pharmaceuticals and intermediates on loan licence basis.  
 
 3. To undertake, promote, encourage, initiate, assist and engage in
 all kinds of research and development work and to set up laboratories
 and other facilities required for the same to render such assistance,
 monetary or otherwise, as may be required for the purpose.
 
 2012
 -Godavari Drugs Ltd has informed that the Board has appointed Mr.
 Mohit Jaju as an Additional Director effective from May 10, 2012
स्रोत: रेलीगरे टेचनोवा

न्यूज़ फ़्लैश

  • MARKET CUES : FIIs ने कैश में `176 Cr की बिकवाली की
  • MARKET CUES : DIIs ने कैश में `326 Cr की बिकवाली की
  • MARKET CUES : FIIs ने F&O में `2532 Cr की बिकवाली की
  • MARKET CUES : इंडेक्स फ्यूचर्स में `927 Cr की बिकवाली
  • MARKET CUES : इंडेक्स ऑप्शंस में `23 Cr की खरीदारी
  • MARKET CUES : स्टॉक फ्यूचर्स में `1739 Cr की बिकवाली
  • MARKET CUES : स्टॉक ऑप्शन में `110.93 Cr की खरीदारी
  • Kotak Instl Eq On L&T : BUY रेटिंग बरकरार, लक्ष्य घटाकर `1550/Sh
  • IDFC Sec On L&T : OUTPERFORM रेटिंग बरकरार, लक्ष्य `1775/Sh
  • IDFC Sec On Axis Bank : OUTPERFORM रेटिंग, लक्ष्य घटाकर `830/Sh

अभी देखें

सौदा आपका

OUR WINNING PICKS

DID YOU INVEST?

INTRADAY PICKS!

(August 06, 2018)

AT (Rs)



GAIN (Rs)

ALL TIME WINNERS

RECO PRICE

PEAK PRICE

OUR PACKAGES

Super Combo

Powerful mix of both trader and investor packs with timely expert advice.

Technical

Designed especially for traders looking to tap the profit opportunities of volatile markets.

Fundamental

For all investors looking to unearth stocks that are poised to move.